If you are a UAE-based researcher running a cut and watching the scale drop while body composition slowly turns soft, the issue is rarely the calorie target — it is the catabolic signal that comes attached to every GLP-1 mono-therapy. The fix that experienced research operators in Dubai, Abu Dhabi and Sharjah have been quietly running through 2025 and into 2026 is a retatrutide + tesamorelin stack: triple-agonist fat-loss on top of a GHRH-driven muscle floor. This is the peptides UAE protocol that decouples weight loss from lean-mass loss, and REVIVE LAB UAE keeps both molecules in stock for same-day delivery across the Emirates.
Below is the dose split, the mechanism rationale, the citations, and a clean way to order retatrutide and tesamorelin from REVIVE LAB UAE — the peptides supplier Dubai researchers default to when timing matters.
Retatrutide is the most aggressive triple agonist in the published literature — GLP-1 + GIP + glucagon receptor activation in a single weekly subcutaneous injection (Jastreboff 2023 NEJM). The Phase 2 obesity trial reported a placebo-adjusted body weight reduction of -17.5% at 48 weeks on the 12 mg arm. That number is the headline. The problem the headline hides is that meta-analyses of GLP-1 class compounds consistently show roughly 25-39% of total weight lost comes from lean tissue when no muscle-sparing intervention is layered in.
For a UAE researcher running a cut — whether in Dubai Marina, on Yas Island, or out in Al Ain — a 17.5% body-weight drop where a third is muscle is not lean recomp. It is just a smaller version of the same physique. The tesamorelin add-on is what flips that ratio.
Tesamorelin is a stabilized GHRH analog. Stanley et al. 2014 (NEJM) and the Falutz 2007/2010 trials showed that 2 mg nightly SC produces a reliable IGF-1 rise plus a selective reduction in visceral adipose tissue — without the appetite, water retention, or carb-cravings that plague exogenous GH. In a calorie-restricted setting (which retatrutide enforces by appetite suppression), the GHRH signal becomes the dominant protein-sparing input.
The two molecules act on completely separate axes, so timing does not need to be coordinated. What does need to be respected is the titration curve on retatrutide — push too fast and the nausea/GI signal will collapse total caloric intake below the lean-mass floor, which defeats the purpose of running tesamorelin underneath it.
| Phase | Retatrutide (weekly SC) | Tesamorelin (nightly SC) | Researcher Note |
|---|---|---|---|
| Weeks 1-4 | 2 mg | 1 mg | Establish tolerance, watch fasting glucose |
| Weeks 5-8 | 4 mg | 1.5 mg | First measurable VAT shift expected |
| Weeks 9-12 | 6-8 mg | 2 mg | Peak deficit window; protein intake critical |
| Weeks 13-16 | 8-12 mg (taper if at target) | 2 mg | Hold or de-escalate retatrutide first |
REVIVE LAB UAE ships 3 mL BAC Water alongside every retatrutide and tesamorelin order, so the lyophilized powder reconstitutes cleanly on arrival. Vial integrity is verified before dispatch — the cold-chain courier does not break temperature between our Dubai facility and your door.
The contrast is the part that matters. Solo retatrutide is a weight-loss tool. The stack is a recomp tool. Here is the directional difference UAE researchers have been reporting back through 2025-2026:
Two flags. First, retatrutide's glucagon activity raises hepatic glucose output — fasting glucose may bump 5-10 mg/dL early; resolves on titration. Second, tesamorelin nudges IGF-1 upward; researchers running both should be tracking IGF-1 through a UAE lab (DM Healthcare, NMC, Aster) every 6-8 weeks to keep it inside the age-adjusted reference range. This is research-use only — no human consumption claims.
REVIVE Peptides UAE operates from Dubai with a cold-chain courier network that covers every emirate. Order before the daily cutoff and the vials are on the road the same business day.
REVIVE Peptides UAE is a Dubai-based research peptides supplier built around three things UAE researchers stopped finding elsewhere: speed, certified purity, and discretion. Every vial — retatrutide 5 mg, retatrutide 10 mg, tesamorelin 5 mg, tesamorelin 10 mg, GHK-Cu 50/100 mg, BPC-157 5 mg, TB-500 5 mg, MOTS-c 10 mg, Semax 10 mg, NAD+ 100 mg — ships with an HPLC certificate of analysis confirming >98% purity. We hold inventory locally so retatrutide is in stock UAE today, not next month from a re-shipper. Browse all REVIVE Peptides UAE products ›
Researchers in Jumeirah, Marina, Business Bay and Palm Jumeirah typically receive their retatrutide same day. Abu Dhabi, Sharjah, Ajman, RAK and Fujairah orders land within 24 hours. Storage on arrival is straightforward: lyophilized powder in the fridge, reconstituted vial in the fridge with a 28-day shelf life on BAC water.
REVIVE LAB UAE — revivelab.ae — stocks HPLC-tested retatrutide 5 mg and 10 mg vials alongside tesamorelin 5 mg and 10 mg vials, with same-day dispatch across Dubai (Marina, JBR, Business Bay, Downtown, Palm Jumeirah, JVC, DIFC) and 24h delivery to Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. Cash on delivery and discreet packaging are standard.
Retatrutide is dosed once weekly subcutaneous, titrated from 2 mg upward over 4-8 weeks per Jastreboff 2023 NEJM. Tesamorelin is dosed nightly subcutaneous at 1-2 mg per Stanley 2014 NEJM. The two molecules act on different axes (incretin/glucagon versus GHRH) so timing does not overlap mechanistically.
Yes — REVIVE LAB UAE operates a cold-chain courier network out of Dubai and dispatches retatrutide same day to Dubai Marina, JBR, Business Bay, Downtown Dubai, Palm Jumeirah, DIFC, JVC, Emirates Hills, Arabian Ranches, Mirdif, Al Barsha, Dubai Hills and MBR City for orders placed before the daily cutoff.